Skip to content

Endometrial Biopsy in Infertile Patients

Utility of the Endometrial Biopsy in the Evaluation of the Luteal Phase

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00064935
Enrollment
880
Registered
2003-07-16
Start date
1999-04-30
Completion date
2002-02-28
Last updated
2005-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

Endometrium, Luteal phase, Endometrial biopsy

Brief summary

When a woman becomes pregnant, the fertilized egg attaches itself to the lining of the uterus (endometrium). The endometrium is constantly changing throughout a woman's menstrual cycle in response to the female hormones estrogen and progesterone. The endometrium must have certain characteristics (be at a specific phase in its cycle) in order for the fertilized egg to successfully attach. Infertility may be caused by an out of phase endometrium (i.e., the endometrium doesn't have the right characteristics when the fertilized egg reaches it). The purpose of this study is to evaluate whether the endometrial biopsy is useful in predicting the potential for becoming pregnant and bearing a child.

Detailed description

This study will evaluate the utility of the endometrial biopsy as a tool for the routine evaluation of the luteal phase of women presenting for infertility evaluation. The study will establish whether the mid-luteal or late-luteal phase is the most appropriate time to perform an endometrial biopsy. The study will be conducted through the multi-center Reproductive Medicine Network. Women with a history of infertility will be age matched to fertile women (controls). Women will be randomized either to the mid-luteal phase (7 to 8 days post-ovulation) endometrial biopsy group or to the late-luteal phase (12 to 13 days post-ovulation) endometrial biopsy group. Endometrial specimens will be evaluated histologically by a blinded pathologist.

Interventions

PROCEDUREEndometrial biopsy

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Lead SponsorNIH

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
DIAGNOSTIC
Masking
DOUBLE

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 39 Years
Healthy volunteers
Yes

Inclusion criteria

for Fertile Patients (controls) * No history of involuntary primary or secondary infertility * Willingness to discontinue hormonal contraceptives for 1 month prior to and through the duration of the study * At least 1 child delivered within 24 months prior to study entry * Most recent pregnancy resulting in a live birth (no interim spontaneous abortions) * Tubal ligation within 24 months of study entry is acceptable if all other criteria are met Inclusion Criteria for Infertile Patients * History of primary or secondary infertility for a period of at least 12 months * No hormonal treatments in the month preceding study entry * No history of tubal ligation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026